Highlights Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Delayed Swiss Exchange 11:36:16 2026-09-18 EDT			5-day change	1st Jan Change
84.50 ^CHF	+1.20%		+0.60%	-14.65%

09-21	Grail rallies as FDA staff flags no major concerns for multi-cancer test	RE
09-18	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI

Highlights

09-18	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI
09-17	Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026	CI
09-17	Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 16 to Holders of Record on Oct. 15	MT
09-15	Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation	CI
09-14	Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations	MT
09-14	Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says	RE
09-08	Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms	CI
08-31	Colorectal Cancer Alliance and Abbott Launch Online Hub Explaining Unexpected Home Delivery Of Colorectal Cancer Screening Kits	CI
08-31	Abbott Launches Similac 360 Total Care Made with Whole Milk Ready-To-Feed Liquid Infant Formula in the United States	CI
08-31	Abbott Laboratories Introduces Similac 360 Total Care Made With Whole Milk in US	MT
08-30	Abbott Presents Positive 12-Month Outcomes for Tactiflex Duo Ablation Catheter in Treating Complex Afib Cases	CI
08-25	Abbott Receives Fda Authorization for Libre Duo 10 Day Dual Glucose-Ketone Sensing Technology	CI
08-25	Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor	MT
08-25	FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients	RE
08-20	Abbott to pay $670 million to settle some preterm infant formula cases	RE
08-20	Abbott Reaches $670 Million Settlement Over Infant Formula Claims	MT
08-20	Abbott to Pay $670 Million to Settle Baby-Formula Litigation	DJ
08-20	Abbott reaches agreements to resolve portion of litigation over infant formula	RE
08-20	Healthtab Ltd and Abbott Enter Multi-Year Collaboration Agreement for Point-Of-Care Testing Across the Uk	CI
08-11	Abbott and Google Launch First-of-its-Kind Partnership to Transform Everyday Health Through Glucose Insights and AI	CI
07-28	Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on October 16, 2024.	CI
07-24	Abbott defeats shareholder lawsuit over 2022 infant formula recall	RE
07-24	Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall	RE
07-17	Abbott investigates two separate cyber incidents, says no operations affected	RE
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT